Question 1

What is the catalog number for Tumor Necrosis Factor Receptor Superfamily Member 9 / CD137 (TNFRSF9) Antibody?

Accepted Answer

The catalog number for Tumor Necrosis Factor Receptor Superfamily Member 9 / CD137 (TNFRSF9) Antibody is abx179031.

Question 2

What sizes are available for Tumor Necrosis Factor Receptor Superfamily Member 9 / CD137 (TNFRSF9) Antibody?

Accepted Answer

Tumor Necrosis Factor Receptor Superfamily Member 9 / CD137 (TNFRSF9) Antibody is available in the following size(s): 1 mL.

Question 3

Is Tumor Necrosis Factor Receptor Superfamily Member 9 / CD137 (TNFRSF9) Antibody in stock?

Accepted Answer

Tumor Necrosis Factor Receptor Superfamily Member 9 / CD137 (TNFRSF9) Antibody is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

How long will it take to receive this product if it’s custom made?

Accepted Answer

Lead times depend on the product type: custom polyclonal antibodies typically take 12-14 weeks, monoclonal antibodies 15-17 weeks, made-to-order recombinant proteins 4-8 weeks, and made-to-order recombinant antibodies 6-8 weeks. These are estimates and may shift due to production delays.

Question 5

What is the recommended dilution for this antibody?

Accepted Answer

A recommended dilution range for each validated application is provided on the datasheet, but optimal dilution should be titrated for your specific experimental system, sample type, and detection method.

Question 6

What is the recommended storage temperature after reconstitution?

Accepted Answer

Post-reconstitution storage guidance is listed on the datasheet, typically requiring aliquoting and storage at -20°C or -80°C to preserve activity.

Tumor Necrosis Factor Receptor Superfamily Member 9 / CD137 (TNFRSF9) Antibody

Product Specifications

Clonality

Conjugation

Applications

Notes

Tested Applications

Host or Source

Frequently Asked Questions

Explore Other Products

Anti-ENT2 Rabbit Monoclonal Antibody

CD45RB (BRA-11G), CF568 conjugate, 0.1mg/mL

VEGF-R2 / CD309 / Flk-1 / KDR3 (DC101), 0.2mg/mL

Carbonic Anhydrase VIII (CPTC-CA8-2), 1mg/mL

AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2784), CF568 conjugate, 0.1mg/mL

Anti-Thrombopoietin/THPO Antibody Picoband®, APC Conjugate